Insider Transactions in Q3 2023 at Catalent, Inc. (CTLT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2023
|
Steven Barg |
BUY
Grant, award, or other acquisition
|
Direct |
718
+50.0%
|
-
|
|
Aug 31
2023
|
Michelle R Ryan |
BUY
Open market or private purchase
|
Direct |
1,000
+33.57%
|
$49,000
$49.98 P/Share
|
|
Aug 30
2023
|
John J Greisch Executive Chair |
BUY
Open market or private purchase
|
Indirect |
21,000
+38.18%
|
$1,050,000
$50.24 P/Share
|
|
Aug 28
2023
|
Stephanie Okey |
BUY
Grant, award, or other acquisition
|
Direct |
979
+50.0%
|
-
|
|
Aug 28
2023
|
Michelle R Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
979
+50.0%
|
-
|
|
Aug 28
2023
|
Frank A Damelio |
BUY
Grant, award, or other acquisition
|
Direct |
979
+50.0%
|
-
|
|
Aug 24
2023
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
817
-1.1%
|
$35,948
$44.65 P/Share
|
|
Aug 24
2023
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Open market or private sale
|
Direct |
396
-0.41%
|
$17,424
$44.49 P/Share
|
|
Aug 24
2023
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
390
-1.57%
|
$17,160
$44.5 P/Share
|
|
Aug 24
2023
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
269
-0.89%
|
$11,836
$44.57 P/Share
|
|
Aug 24
2023
|
Alessandro Maselli President & CEO |
SELL
Open market or private sale
|
Direct |
2,071
-1.15%
|
$91,124
$44.83 P/Share
|
|
Aug 24
2023
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
276
-1.24%
|
$12,144
$44.56 P/Share
|
|
Aug 24
2023
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
SELL
Open market or private sale
|
Direct |
87
-0.15%
|
$3,828
$44.87 P/Share
|
|
Aug 24
2023
|
Lorenzo Carletti SVP Global Ops Ph & Cons Hlth |
SELL
Open market or private sale
|
Direct |
216
-2.41%
|
$9,504
$44.71 P/Share
|
|
Aug 24
2023
|
Charles Lickfold SVP, CIO |
SELL
Open market or private sale
|
Direct |
190
-1.65%
|
$8,360
$44.72 P/Share
|
|
Aug 24
2023
|
Thomas W Hawkeswood Pres. Pharma Prod Delivery Div |
SELL
Open market or private sale
|
Direct |
147
-1.91%
|
$6,468
$44.72 P/Share
|
|
Aug 24
2023
|
Patricia Hunt Pres. Consumer Health Div |
SELL
Open market or private sale
|
Direct |
106
-0.93%
|
$4,664
$44.77 P/Share
|
|
Aug 24
2023
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
379
-1.24%
|
$16,676
$44.47 P/Share
|
|
Aug 23
2023
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,226
+2.91%
|
-
|
|
Aug 23
2023
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
1,590
+1.61%
|
-
|
|
Aug 23
2023
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+4.29%
|
-
|
|
Aug 23
2023
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
1,081
+3.46%
|
-
|
|
Aug 23
2023
|
Alessandro Maselli President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,974
+4.23%
|
-
|
|
Aug 23
2023
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
789
+3.49%
|
-
|
|
Aug 23
2023
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
BUY
Grant, award, or other acquisition
|
Direct |
1,590
+2.69%
|
-
|
|
Aug 23
2023
|
Lorenzo Carletti SVP Global Ops Ph & Cons Hlth |
BUY
Grant, award, or other acquisition
|
Direct |
457
+4.85%
|
-
|
|
Aug 23
2023
|
Charles Lickfold SVP, CIO |
BUY
Grant, award, or other acquisition
|
Direct |
637
+5.24%
|
-
|
|
Aug 23
2023
|
Thomas W Hawkeswood Pres. Pharma Prod Delivery Div |
BUY
Grant, award, or other acquisition
|
Direct |
268
+3.37%
|
-
|
|
Aug 23
2023
|
Patricia Hunt Pres. Consumer Health Div |
BUY
Grant, award, or other acquisition
|
Direct |
289
+2.47%
|
-
|
|
Aug 23
2023
|
Ricardo Pravda Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,081
+3.41%
|
-
|
|
Aug 01
2023
|
Karen Murphy Santiago VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,342
+32.96%
|
-
|
|
Aug 01
2023
|
Ricardo Zayas SVP, Operations, Biologics NA |
BUY
Grant, award, or other acquisition
|
Direct |
4,435
+41.61%
|
-
|
|
Aug 01
2023
|
Ricardo Pravda Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,783
+24.89%
|
-
|
|
Aug 01
2023
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
269
-0.67%
|
$12,643
$47.14 P/Share
|
|
Aug 01
2023
|
Alessandro Maselli President & CEO |
SELL
Open market or private sale
|
Direct |
1,485
-0.85%
|
$69,795
$47.23 P/Share
|
|
Aug 01
2023
|
Charles Lickfold SVP, CIO |
BUY
Grant, award, or other acquisition
|
Direct |
5,322
+32.82%
|
-
|
|
Aug 01
2023
|
Charles Lickfold SVP, CIO |
SELL
Open market or private sale
|
Direct |
135
-2.37%
|
$6,345
$47.9 P/Share
|
|
Aug 01
2023
|
Joseph Anthony Ferraro SVP, General Counsel, CCO |
BUY
Grant, award, or other acquisition
|
Direct |
5,145
+50.0%
|
-
|
|
Aug 01
2023
|
Patricia Hunt Pres. Consumer Health Div |
BUY
Grant, award, or other acquisition
|
Direct |
1,952
+14.95%
|
-
|
|
Aug 01
2023
|
Patricia Hunt Pres. Consumer Health Div |
SELL
Open market or private sale
|
Direct |
161
-1.73%
|
$7,567
$47.95 P/Share
|
|
Aug 01
2023
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+18.54%
|
-
|
|
Aug 01
2023
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
195
-1.19%
|
$9,165
$47.86 P/Share
|
|
Aug 01
2023
|
Thomas W Hawkeswood Pres. Pharma Prod Delivery Div |
BUY
Grant, award, or other acquisition
|
Direct |
2,306
+23.73%
|
-
|
|
Aug 01
2023
|
Thomas W Hawkeswood Pres. Pharma Prod Delivery Div |
SELL
Open market or private sale
|
Direct |
258
-4.81%
|
$12,126
$47.97 P/Share
|
|
Aug 01
2023
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
5,322
+15.45%
|
-
|
|
Aug 01
2023
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
190
-0.79%
|
$8,930
$47.9 P/Share
|
|
Aug 01
2023
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
6,209
+20.74%
|
-
|
|
Aug 01
2023
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
276
-0.78%
|
$12,972
$47.26 P/Share
|
|
Aug 01
2023
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
8,870
+8.51%
|
-
|
|
Aug 01
2023
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Open market or private sale
|
Direct |
281
-0.16%
|
$13,207
$47.23 P/Share
|